Division of Physicians: Basic Sciences Across Physician Specialties
Division of Physicians: Basic Sciences for Physician Specialties
This domain tests how basic science explains physician practice across family medicine, internal medicine, laboratory medicine, oncology and radiotherapy, paediatrics, psychiatry, public health, and radiology. Questions rarely ask isolated facts; they ask you to apply mechanism to a clinical decision, investigation, or prevention programme. Use a cause-to-consequence chain: normal structure/function → disturbed mechanism → clinical sign → test result → treatment or prevention.
Core rules and concepts
- Homeostasis and control: disease emerges when feedback fails. Examples include baroreceptor response in shock, insulin/glucagon balance in hypoglycaemia, and acid-base compensation in vomiting or diarrhoea.
- Structure-function: anatomy and histology predict clinical signs. A left ventricular aneurysm after myocardial infarction predisposes to mural thrombus and embolism; a renal tubular defect changes electrolyte handling.
- Pathology and neoplasia: inflammation, repair, and cell cycle control explain chronic disease and cancer. Radiotherapy exploits DNA damage and fractionation to spare normal tissue.
- Pharmacology: pharmacokinetics and pharmacodynamics determine dosing, interactions, and toxicity, especially in renal or hepatic impairment and in children.
- Microbiology and immunity: virulence, transmission, and host defence guide diagnosis and antibiotic choice.
- Epidemiology and public health: study design, bias, screening criteria, and outbreak investigation underpin prevention.
- Laboratory medicine: pre-analytical error, sensitivity, specificity, predictive values, and quality control determine whether a result is trustworthy.
- Psychiatry: neurotransmitter systems, psychopharmacology, and biopsychosocial formulation explain mental state and treatment.
- Radiology: modality physics, contrast, and radiation safety determine appropriate imaging.
Worked example
A 55-year-old man presents with sudden pleuritic chest pain and breathlessness after travel. You consider pulmonary embolism. Pre-test probability is assessed with a validated clinical score; in a low-probability patient, a highly sensitive D-dimer can exclude PE, but in a high-probability patient, imaging is needed. CTPA detects clot and also reveals alternative diagnoses, but involves contrast and radiation. The reasoning is probabilistic: test performance depends on prevalence, so a negative D-dimer is most useful when pre-test probability is low. Treating the D-dimer as a diagnostic test in all patients causes false reassurance and unnecessary imaging.
Traps that cost marks
- Confusing sensitivity with positive predictive value, or ignoring prevalence.
- Forgetting renal or hepatic dose adjustment.
- Treating a laboratory number without the clinical context.
- Mixing screening with diagnostic testing.
- Missing paediatric weight-based dosing or developmental physiology.
- Attributing psychiatric symptoms to social factors without excluding organic causes.